![]() |
Volumn 97, Issue 4, 2008, Pages 350-359
|
Gastrointestinal stromal tumors and leiomyosarcomas
|
Author keywords
GIST; Leiomyosarcoma; Sarcoma
|
Indexed keywords
FLUORODEOXYGLUCOSE F 18;
IMATINIB;
PLACEBO;
ADJUVANT THERAPY;
CANCER CHEMOTHERAPY;
CANCER INVASION;
CANCER SURGERY;
CANCER THERAPY;
CELL PROLIFERATION;
CLINICAL FEATURE;
CLINICAL TRIAL;
COMPUTER ASSISTED TOMOGRAPHY;
DRUG BINDING;
DRUG DOSE COMPARISON;
DRUG RESPONSE;
GASTROINTESTINAL STROMAL TUMOR;
GENE MUTATION;
HISTOLOGY;
HUMAN;
LAPAROTOMY;
LEIOMYOSARCOMA;
METASTASIS;
MITOSIS RATE;
MULTIMODALITY CANCER THERAPY;
NUCLEAR MAGNETIC RESONANCE IMAGING;
POSITRON EMISSION TOMOGRAPHY;
PRIORITY JOURNAL;
PROGNOSIS;
REVIEW;
STAINING;
TREATMENT OUTCOME;
TUMOR LOCALIZATION;
TUMOR VOLUME;
UNSPECIFIED SIDE EFFECT;
ALGORITHMS;
COMBINED MODALITY THERAPY;
GASTROINTESTINAL STROMAL TUMORS;
HUMANS;
LEIOMYOSARCOMA;
PROGNOSIS;
|
EID: 40549118843
PISSN: 00224790
EISSN: 10969098
Source Type: Journal
DOI: 10.1002/jso.20970 Document Type: Review |
Times cited : (115)
|
References (96)
|